Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
antiviral drug
imidazole derivative |
| gptkbp:affiliatedWith |
imidazole antifungals
|
| gptkbp:approvedBy |
gptkb:Spain
several European countries |
| gptkbp:ATCCode |
D01AC18
|
| gptkbp:CASNumber |
99592-32-2
|
| gptkbp:chemicalFormula |
C20H15Cl3N2O2S
|
| gptkbp:compatibleWith |
gptkb:United_States
|
| gptkbp:developedBy |
Ferrer Internacional
|
| gptkbp:drugClass |
antifungal
|
| https://www.w3.org/2000/01/rdf-schema#label |
sertaconazole
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
inhibits ergosterol synthesis
disrupts fungal cell membrane |
| gptkbp:molecularWeight |
451.8 g/mol
|
| gptkbp:pregnancyCategory |
gptkb:C_(Australia)
|
| gptkbp:routeOfAdministration |
topical
|
| gptkbp:sideEffect |
itching
burning sensation local irritation |
| gptkbp:synonym |
sertaconazole nitrate
|
| gptkbp:usedFor |
treatment of athlete's foot
treatment of cutaneous candidiasis treatment of fungal skin infections treatment of tinea corporis treatment of tinea cruris |
| gptkbp:bfsParent |
gptkb:D01AE25
|
| gptkbp:bfsLayer |
7
|